Anti-TNF-related apoptosis-inducing ligand receptor 2 and anti-cadherin 17 binding bispecific molecules for treatment of cancer

摘要

The present invention relates to binding molecules that specifically bind to TNF-related apoptosis-inducing ligand receptor 2 (TRAIL2) and cadherin-17 (CDH17), and their use in medicine, pharmaceutical compositions containing them, and It relates to a method of using it as an agent for the treatment and / or prevention of cancer.